Targeting type 2 inflammation in bullous pemphigoid: dupilumab as a game changer opens new avenues

被引：0
|
作者：
Borradori, Luca [1 ]
Hertl, Michael [2 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Dept Dermatol, Bern, Switzerland
[2] Philipps Univ, Dept Dermatol & Allergol, Marburg, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2025年 / 192卷 / 03期
关键词：
D O I：
10.1093/bjd/ljae465
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：377 / 378
页数：2
相关论文
共 50 条
  • [21] Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
    Bhatt, Surya P.
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus F.
    Bafadhel, Mona
    Christenson, Stephanie A.
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Patel, Naimish
    Yancopoulos, George D.
    Akinlade, Bolanle
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Abdulai, Raolat M.
    Robinson, Lacey B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (24): : 2274 - 2283
  • [22] Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
    Bhatt, S. P.
    Rabe, K. F.
    Hanania, N. A.
    Vogelmeier, C. F.
    Cole, J.
    Bafadhel, M.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Mannent, L. P.
    Patel, N.
    Staudinger, H. W.
    Yancopoulos, G. D.
    Mortensen, E. R.
    Akinlade, B.
    Maloney, J.
    Lu, X.
    Bauer, D.
    Bansal, A.
    Robinson, L. B.
    Abdulai, R. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (03): : 205 - 214
  • [23] Augmentation of Cognitive Training With Vortioxetine Opens New Avenues for Targeting Age-Related Changes in Brain Connectivity
    Jaywant, Abhishek
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (06): : 398 - 400
  • [24] A Comparison for Type 2 Cytokines and Lesional Inflammatory Infiltrations in Bullous Pemphigoid and Atopic Dermatitis
    Hu, Yu-qing
    Zhang, Jian-zhong
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2313 - 2321
  • [25] Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report
    Fukuda, Gen
    Yoshida, Tomohiko
    Hirayama, Arisa
    Umezawa, Yoshinori
    Takemoto, Minoru
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (12) : 1289 - 1290
  • [26] A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation
    Trimarchi, Matteo
    Vinciguerra, Alessandro
    Rampi, Andrea
    Tanzini, Umberto
    Nonis, Alessandro
    Yacoub, Mona Rita
    Bussi, Mario
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2022, 42 (06) : 538 - 544
  • [27] New-onset bullous pemphigoid after SARS-CoV-2 infection
    Zhoi, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S335 - S335
  • [28] Targeting inflammation in the treatment of type 2 diabetes
    Donath, M. Y.
    DIABETES OBESITY & METABOLISM, 2013, 15 : 193 - 196
  • [29] Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid
    Leisti, Paivi
    Pankakoski, Anna
    Jokelainen, Jari
    Huilaja, Laura
    Panelius, Jaana
    Tasanen, Kaisa
    Varpuluoma, Outi
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [30] Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
    Douros, Antonios
    Rouette, Julie
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (08) : 1496 - 1503
12345